Atlas Trials

Relapse/Recurrence

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapse/Recurrence

RecordFirmDate
A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451)Lyell Immunopharma, Inc.2022-03-29
Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma (NCT04689659)Beijing Boren Hospital2021-12-01
Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma (NCT05320081)Huazhong University of Science and Technology2021-11-30
Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS (NCT04749355)BioSight Ltd.2021-11-14
Study of Lacutamab in Peripheral T-cell Lymphoma (NCT04984837)The Lymphoma Academic Research Organisation2021-10-05
A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma (NCT04860674)Zhejiang Cancer Hospital2021-05-01
Dual Target CAR-T Cells in B-cell Lymphoma (NCT04723914)YuLi2020-10-20
The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung (NCT04634630)Beatrice Aramini2017-10-17
Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound (NCT03501758)Haukeland University Hospital2017-01-17

Track Relapse/Recurrence automatically

Every clearance here is in the API, with alerts when new ones post.